Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS)
CNY 29.71
(4.39%)
CNY 29.71
(4.39%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.83 CNY | 15.28% |
| 2022 | 0.72 CNY | -7.69% |
| 2021 | 0.78 CNY | 1.3% |
| 2020 | 0.77 CNY | -21.43% |
| 2019 | 0.98 CNY | -14.04% |
| 2018 | 1.14 CNY | 3.64% |
| 2017 | 1.10 CNY | 46.67% |
| 2016 | 0.75 CNY | -29.91% |
| 2015 | 1.07 CNY | 35.44% |
| 2014 | 0.79 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.34 CNY | 30.77% |
| 2024 Q3 | 0.25 CNY | -26.47% |
| 2024 Q1 | 0.26 CNY | -40.91% |
| 2023 Q4 | 0.44 CNY | 131.58% |
| 2023 FY | - CNY | 15.28% |
| 2023 Q3 | 0.19 CNY | -5.0% |
| 2023 Q1 | 0.20 CNY | 66.67% |
| 2023 Q2 | 0.20 CNY | 0.0% |
| 2022 Q1 | 0.21 CNY | 31.25% |
| 2022 FY | - CNY | -7.69% |
| 2022 Q4 | 0.12 CNY | -14.29% |
| 2022 Q3 | 0.14 CNY | -44.0% |
| 2022 Q2 | 0.25 CNY | 19.05% |
| 2021 Q1 | 0.20 CNY | 5.26% |
| 2021 Q3 | 0.21 CNY | -8.7% |
| 2021 Q4 | 0.16 CNY | -23.81% |
| 2021 FY | - CNY | 1.3% |
| 2021 Q2 | 0.23 CNY | 15.0% |
| 2020 FY | - CNY | -21.43% |
| 2020 Q4 | 0.19 CNY | 35.71% |
| 2020 Q3 | 0.14 CNY | -26.32% |
| 2020 Q2 | 0.19 CNY | -20.83% |
| 2020 Q1 | 0.24 CNY | 84.62% |
| 2019 Q2 | 0.32 CNY | 3.23% |
| 2019 FY | - CNY | -14.04% |
| 2019 Q1 | 0.31 CNY | 10.71% |
| 2019 Q4 | 0.13 CNY | -50.0% |
| 2019 Q3 | 0.26 CNY | -18.75% |
| 2018 Q2 | 0.35 CNY | 25.0% |
| 2018 FY | - CNY | 3.64% |
| 2018 Q4 | 0.28 CNY | 16.67% |
| 2018 Q3 | 0.24 CNY | -31.43% |
| 2018 Q1 | 0.28 CNY | 12.0% |
| 2017 Q2 | 0.31 CNY | 0.0% |
| 2017 Q3 | 0.22 CNY | -29.03% |
| 2017 Q4 | 0.25 CNY | 13.64% |
| 2017 Q1 | 0.31 CNY | 0.0% |
| 2017 FY | - CNY | 46.67% |
| 2016 FY | - CNY | -29.91% |
| 2015 FY | - CNY | 35.44% |
| 2014 FY | - CNY | 0.0% |